Diabetes: Can you reverse symptoms in FOUR weeks? Diet secret to cure condition revealed

TYPE 2 DIABETES is a big problem for the UK. Four million people in the UK have type 2 diabetes and 12 million more at at risk. Can you reverse diabetes with your diet? This TV experiment The Fast Fix aims to find out.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
This article overviews studies on epidemiology and impact of gastroparesis in the setting of type 1 and type 2 diabetes, with a view to estimating the possible burden of gastrointestinal dysfunction in PPDM. Further, the usefulness of quantifying gastrointestinal dysmotility is discussed. The gastroparesis cardinal symptom index has emerged as a standardised gastrointestinal dysmotility endpoint and its use in individuals after pancreatitis is justified. PMID: 29914234 [PubMed - as supplied by publisher]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
Authors: Chen Y, Men K, Li XF, Li J, Liu M, Fan ZQ Abstract OBJECTIVE: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agents for type 2 diabetes mellitus (T2DM) patients. However, the effects and safety of DPP-4 inhibitors in T2DM patients with renal impairment (RI) remain controversial. Therefore, we conducted this meta-analysis to assess the efficacy and safety of DPP-4 inhibitors in T2DM patients with moderate to severe RI. MATERIALS AND METHODS: The PubMed, Embase, and Web of Science database were searched for published randomized controlled trials (RCTs), which compared DPP-...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
The future of diabetes management could be coming soon. A global innovation competition is underway to find digital solutions that can help transform type 2 diabetes management. Type 2 diabetes currently accounts for around 90% of the estimated 425 million people with diabetes globally, and new, innovative ways to manage this condition are urgently required to meet the substantial and growing burden to patients and our healthcare systems. That is exactly what the Ascensia Diabetes Challenge has been designed to do – find ideas that are out there and have the potential to make a difference to Type 2 diabetes managemen...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
WEDNESDAY, June 20, 2018 -- Americans with severe mental illness are more than twice as likely to develop type 2 diabetes, and the increased risk is highest among minorities, a new study suggests. Researchers looked at more than 15,000 patients with...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Condition:   T2DM Interventions:   Drug: CSII+Vildagliptin;   Drug: CSII(insulin Lispro) Sponsor:   The First Affiliated Hospital of Xiamen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   T2DM Intervention:   Device: Magnetic resonance Sponsor:   Kunming Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: Infants of diabetic mothers in this cohort developed a variety of neonatal events that  largely correlates with poor metabolic control during pregnancy. PMID: 29915854 [PubMed - in process]
Source: Saudi Medical Journal - Category: Middle East Health Tags: Saudi Med J Source Type: research
Background: Type 2 diabetes, chronic kidney disease (CKD) and its cardiovascular complications are increasing as health problems worldwide. These diseases are interrelated with overlapping occurrence and once diabetes is established, the risk of cardiorenal disease is dramatically elevated. Thus, a search for unifying modifiable risk factors is key for effective prevention.Summary: Elevated fasting plasma concentration of vasopressin, measured with the marker copeptin, predicts new onset type 2 diabetes as well as renal function decline. Furthermore, we recently showed that increased plasma copeptin concentration independe...
Source: Annals of Nutrition and Metabolism - Category: Nutrition Source Type: research
Background: Diabetic nephropathy has become the most common cause of chronic kidney disease (CKD). Despite the progress accomplished in therapy, the prevalence of renal disorders remains high. Some modifiable factors driving the increase in incidence of CKD, in diabetes and other settings, might have been overlooked. Consistent evidence supports a role for vasopressin, hydration state, and urine concentration in kidney health.Summary: Plasma vasopressin is elevated in diabetes, even if metabolic control is good. Several epidemiological studies have pointed to a positive association between markers of vasopressin secretion ...
Source: Annals of Nutrition and Metabolism - Category: Nutrition Source Type: research
More News: Diabetes | Diabetes Type 2 | Diets | Endocrinology | Health | Nutrition